Search

Search Constraints

You searched for: Author/Creator Houot, Roch

Search Results

31. Management and outcome of primary CNS lymphoma in the modern era: An LOC network study. (10th March 2020)

32. Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group. Issue 11 (November 2020)

34. Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study. Issue 8 (August 2019)

35. Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase. Issue 12 (2nd December 2018)

36. Patients Participating in Nasogastric Tube Insertion through Hypnoanalgesia during High-dose Chemotherapy-induced Aplasia. Issue 1 (2nd January 2023)

37. Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma. Issue 4 (21st March 2022)

38. Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network. Issue 9 (1st September 2016)

39. Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. Issue 2 (10th February 2022)

40. Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study. Issue 32 (10th November 2022)